Peptide Surf a research-only wiki of supplements & peptides
Research & educational use only. This site catalogs published research and public commentary about supplements and peptides. It is not medical advice and not a recommendation to use any compound. Consult a qualified clinician.
← Catalog

Retatrutide

peptide Metabolic & Weight Management

An investigational triple agonist hitting the GLP-1, GIP, and glucagon receptors. Described as the strongest of the GLP-1-class "cousins". Not yet approved, but reported Phase 3 data is strong.

Synonyms

LY3437943 · chemical triple agonist · other GLP-1/GIP/glucagon agonist · other

Synonyms drive on-site search and are used to index ingested research papers and tweets to this page.

Safety

research only Not an approved drug or dietary supplement. Cataloged for educational purposes only.

Contraindications

  • Not approved by the FDA; investigational

Reported side effects

  • Expected GI effects consistent with the incretin class (per trials)

Investigational. This page summarizes public commentary and is not medical advice or a recommendation for use.

Protocols

No structured protocols recorded.

Claims & evidence

Produces weight loss via triple GLP-1/GIP/glucagon receptor agonism; Phase 3 trials reported as strong.

Weight loss positive human-rct

Anecdotally eliminates "food noise" and is microdosed by some for focus and adherence.

Appetite / focus positive anecdotal

Notes

Overview

Retatrutide adds glucagon-receptor activity on top of the GLP-1/GIP mechanism. It remains experimental; the “food noise” account is the source author’s subjective, non-clinical experience.